NASDAQ:NMTC NeuroOne Medical Technologies (NMTC) Stock Price, News & Analysis $0.81 +0.01 (+0.95%) As of 10:34 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About NeuroOne Medical Technologies Stock (NASDAQ:NMTC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get NMTC alerts:Sign Up Key Stats Today's Range$0.77▼$0.8450-Day Range$0.76▼$1.6952-Week Range$0.75▼$6.12Volume5,015 shsAverage Volume131,898 shsMarket Capitalization$7.38 millionP/E RatioN/ADividend YieldN/APrice Target$7.33Consensus RatingHold Company Overview NeuroOne Medical Technologies Corp. (NASDAQ: NMTC) is a medical device company focused on developing thin-film electrode technology for neurological applications. Its products are designed to support the diagnosis, monitoring and treatment of disorders affecting the brain and nervous system. The company’s product portfolio includes the Evo cortical and stereoelectroencephalography (sEEG) electrode systems, which are used by clinicians to record electrical activity in the brain and help evaluate patients with conditions such as epilepsy. NeuroOne has also developed technology intended to enable therapeutic procedures, including radiofrequency ablation, through its electrode platforms. NeuroOne is headquartered in Eden Prairie, Minnesota, and serves the neurosurgical and neurology markets through medical-device sales and relationships with healthcare providers and distribution partners. Its technology is intended for use in hospitals and other clinical settings, with regulatory clearances supporting commercialization of certain products in the United States.AI Generated. May Contain Errors. Read More NeuroOne Medical Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks78th Percentile Overall ScoreNMTC MarketRank™: 3.902007083825 of 5 starsNeuroOne Medical Technologies scored higher than 78% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingNeuroOne Medical Technologies has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialNeuroOne Medical Technologies has a consensus price target of $7.33, representing about 820.1% upside from its current price of $0.80.Amount of Analyst CoverageNeuroOne Medical Technologies has only been the subject of 2 research reports in the past 90 days.Read more about NeuroOne Medical Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for NeuroOne Medical Technologies are expected to decrease in the coming year, from ($0.39) to ($0.71) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of NeuroOne Medical Technologies is -0.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeuroOne Medical Technologies is -0.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNeuroOne Medical Technologies has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about NeuroOne Medical Technologies' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.58% of the float of NeuroOne Medical Technologies has been sold short.Short Interest Ratio / Days to CoverNeuroOne Medical Technologies has a short interest ratio ("days to cover") of 2.39, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeuroOne Medical Technologies has recently decreased by 0.12%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNeuroOne Medical Technologies does not currently pay a dividend.Dividend GrowthNeuroOne Medical Technologies does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.91 News SentimentNeuroOne Medical Technologies has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for NeuroOne Medical Technologies this week, compared to 2 articles on an average week.MarketBeat Follows2 people have added NeuroOne Medical Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership3.5 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $66,999.00 in company stock, which represents 0.9228% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, NeuroOne Medical Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $66,999.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders11.80% of the stock of NeuroOne Medical Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions16.07% of the stock of NeuroOne Medical Technologies is held by institutions.Read more about NeuroOne Medical Technologies' insider trading history. Receive NMTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NMTC Stock News HeadlinesThinner devices, bigger possibilities: The business behind NeuroOne's neurological innovationNovember 11 at 7:31 AM | msn.comNeuroOne® Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation SystemOctober 29, 2026 | globenewswire.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.November 12 at 1:00 AM | Weiss Ratings (Ad)NeuroOne Medical Technologies Corporation Highlights Successful Treatment Using OneRF Trigeminal Nerve Ablation SystemOctober 28, 2026 | marketscreener.comMNeuroOne Featured in New York Post on OneRF® Patient’s Remarkable Journey to Overcome Debilitating Facial PainOctober 27, 2026 | markets.businessinsider.comNeuroOne Featured in New York Post on OneRF® Patient's Remarkable Journey to Overcome Debilitating Facial PainOctober 27, 2026 | globenewswire.comNeuroone Secures First Pharmaceutical Industry Purchase Order for Stereocedtm Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research ProgramOctober 23, 2026 | marketscreener.comMNeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research ProgramOctober 22, 2026 | globenewswire.comSee More Headlines NMTC Stock Analysis - Frequently Asked Questions How have NMTC shares performed this year? NeuroOne Medical Technologies' stock was trading at $4.5480 on January 1st, 2026. Since then, NMTC stock has decreased by 82.5% and is now trading at $0.7970. How were NeuroOne Medical Technologies' earnings last quarter? NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) posted its quarterly earnings data on Thursday, August, 13th. The company reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by $0.07. The firm earned $1.97 million during the quarter, compared to the consensus estimate of $2.17 million. NeuroOne Medical Technologies had a negative trailing twelve-month return on equity of 128.12% and a negative net margin of 71.50%. Read the conference call transcript. When did NeuroOne Medical Technologies' stock split? Shares of NeuroOne Medical Technologies reverse split before market open on Wednesday, April 15th 2026.A 1-6 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 14th 2026. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. When did NeuroOne Medical Technologies IPO? NeuroOne Medical Technologies (NMTC) raised $500,000 in an IPO on Wednesday, May 26th 2021. The company issued 10,000,000 shares at $0.05 per share. How do I buy shares of NeuroOne Medical Technologies? Shares of NMTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NeuroOne Medical Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroOne Medical Technologies investors own include NVIDIA (NVDA), Nokia (NOK), Advanced Micro Devices (AMD), NIO (NIO), Tesla (TSLA), Dell Technologies (DELL) and Lithium Americas (LAC). Company Calendar Last Earnings8/13/2026Today11/12/2026Next Earnings (Estimated)12/15/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (4m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 NMTC's financial health is in the Red zone, according to TradeSmith. NMTC has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:NMTC CIK1500198 Webwww.n1mtc.com Phone(952) 426-1383FaxN/AEmployees18Year FoundedN/APrice Target and Rating Average Price Target for NeuroOne Medical Technologies$7.33 High Price Target$9.00 Low Price Target$5.00 Potential Upside/Downside+805.3%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.95) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.61 million Net Margins-71.50% Pretax Margin-74.46% Return on Equity-128.12% Return on Assets-86.34% Debt Debt-to-Equity RatioN/A Current Ratio2.84 Quick Ratio1.71 Sales & Book Value Annual Sales$12.10 million Price / Sales0.61 Cash FlowN/A Price / Cash FlowN/A Book Value$0.85 per share Price / Book0.95Miscellaneous Outstanding Shares9,110,000Free Float8,031,000Market Cap$7.38 million OptionableOptionable Beta0.95 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NASDAQ:NMTC) was last updated on 11/12/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredTrump, Schiff and Dalio all point to the same warning signIn 1929, the Dow fell 89 percent and took 25 years to recover. A 60-year-old who held on wasn't made whole unt...USA Capital Gold | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredWatch This NowJensen Huang, the man who launched the AI boom, just called what Elon Musk is chasing "the final frontier of A...StocksToTrade | SponsoredDemocrats can stall every bill. They can’t stop this Trump order.The U.S. owns 8,133 tonnes of gold, still valued on the books at $42.22 an ounce. That price was set in 1973 a...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMTC Stock Alerts